Jacobs Levy Equity Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.17M | Buy |
30,141
+15,577
| +107% | +$887K | 0.01% | 578 |
|
|
2025
Q4 | $616K | Sell |
14,564
-382
| -3% | -$21.4K | ﹤0.01% | 767 |
|
|
2025
Q3 | $850K | Sell |
14,946
-133,294
| -90% | -$4.41M | ﹤0.01% | 748 |
|
|
2025
Q2 | $3.83M | Sell |
148,240
-52,289
| -26% | -$587K | 0.02% | 501 |
|
|
2025
Q1 | $2.05M | Buy |
200,529
+25,398
| +15% | +$332K | 0.01% | 656 |
|
|
2024
Q4 | $2.44M | Sell |
175,131
-11,083
| -6% | -$195K | 0.01% | 559 |
|
|
2024
Q3 | $3.63M | Sell |
186,214
-5,332
| -3% | -$102K | 0.01% | 499 |
|
|
2024
Q2 | $3.56M | Buy |
191,546
+64,134
| +50% | +$1.35M | 0.01% | 500 |
|
|
2024
Q1 | $1.79M | Sell |
127,412
-99,532
| -44% | -$1.04M | 0.01% | 617 |
|
|
2023
Q4 | $1.92M | Sell |
226,944
-100,039
| -31% | -$758K | 0.01% | 609 |
|
|
2023
Q3 | $2.92M | Buy |
326,983
+2,284
| +0.7% | +$22K | 0.02% | 491 |
|
|
2023
Q2 | $2.8M | Buy |
324,699
+150,160
| +86% | +$1.6M | 0.02% | 507 |
|
|
2023
Q1 | $1.84M | Buy |
174,539
+3,149
| +2% | +$95.3K | 0.01% | 589 |
|
|
2022
Q4 | $5.81M | Buy |
171,390
+102,195
| +148% | +$4.95M | 0.04% | 366 |
|
|
2022
Q3 | $3.32M | Buy |
69,195
+53,997
| +355% | +$3.21M | 0.03% | 467 |
|
|
2022
Q2 | $866K | Buy |
+15,198
| New | +$959K | 0.01% | 781 |
|
|
2022
Q1 | – | Sell |
-6,194
| Closed | -$1.25M | – | 1049 |
|
|
2021
Q4 | $1.25M | Buy |
6,194
+389
| +7% | +$84.4K | 0.01% | 705 |
|
|
2021
Q3 | $1.56M | Buy |
5,805
+4,106
| +242% | +$987K | 0.01% | 664 |
|
|
2021
Q2 | $437K | Buy |
1,699
+392
| +30% | +$108K | ﹤0.01% | 889 |
|
|
2021
Q1 | $392K | Sell |
1,307
-3,725
| -74% | -$1.16M | ﹤0.01% | 897 |
|
|
2020
Q4 | $1.28M | Sell |
5,032
-87
| -2% | -$22.5K | 0.01% | 664 |
|
|
2020
Q3 | $1.27M | Buy |
5,119
+1,217
| +31% | +$383K | 0.01% | 609 |
|
|
2020
Q2 | $1.35M | Buy |
+3,902
| New | +$1.22M | 0.01% | 604 |
|
|
2016
Q2 | – | Sell |
-792
| Closed | -$163K | – | 1203 |
|
|
2016
Q1 | $163K | Buy |
+792
| New | +$152K | ﹤0.01% | 995 |
|
|
2015
Q3 | – | Sell |
-18,583
| Closed | -$3.49M | – | 852 |
|
|
2015
Q2 | $3.49M | Buy |
18,583
+11,466
| +161% | +$1.97M | 0.07% | 276 |
|
|
2015
Q1 | $1.17M | Sell |
7,117
-25,509
| -78% | -$5.24M | 0.02% | 447 |
|
|
2014
Q4 | $7.58M | Buy |
32,626
+8,507
| +35% | +$1.82M | 0.13% | 200 |
|
|
2014
Q3 | $4.37M | Buy |
24,119
+4,560
| +23% | +$873K | 0.07% | 260 |
|
|
2014
Q2 | $3.76M | Buy |
+19,559
| New | +$3.46M | 0.06% | 310 |
|
|
2014
Q1 | – | Sell |
-5,614
| Closed | -$956K | – | 974 |
|
|
2013
Q4 | $956K | Sell |
5,614
-1,278
| -19% | -$206K | 0.01% | 583 |
|
|
2013
Q3 | $1.08M | Buy |
+6,892
| New | +$1.27M | 0.02% | 517 |
|
Other funds holding NKTR
BI
TSC
VCM
PM
AC
